- AdventHealth
Surgeons at the AdventHealth Transplant Institute recently performed the 1,000th transplant in the program’s history.
The institute, Central Florida’s only solid organ transplant center, offers Floridians access to a top liver transplant center without leaving the state.
“We're able to handle one of the most difficult surgeries and continue to do so with excellent outcomes,” said Dr. Thomas Chin, the director of liver transplant who came to the institute in 2007 to start the liver transplant program. “I think that should bring a lot of confidence.”
The surgical team for the 1,000th procedure was led by Dr. Michael Angelis, assisted by surgeons, Dr. Phillip Wai and Chin.
“I think the fact that we’ve gotten here after just about 15-years is a tremendous accomplishment,” Chin said. “It’s very gratifying that we can really affect someone’s life in such a positive manner.”
Shelly Kalahar, the institute’s 716th liver transplant patient, said AdventHealth has, “The best people, the best doctors, the best surgeons, the best nurses. They’re the best people I’ve ever met in my life!”
Kalahar said her transplant has allowed her to spend five more Thanksgivings, and counting, with her family. She also pointed out how meaningful it is to belong to that exclusive group of AdventHealth Transplant Institute’s first 1,000 liver transplants.
“Oh, I think it’s awesome. It saved my life. A thousand people got to live longer,” Kalahar said.
Watch the video above to see Kalahari's inspiring and surprising personal transplant journey.
Many of the innovations and programs at the AdventHealth Transplant Institute are funded through philanthropy. Among them is the Bartch Transplant House — a home-away-from-home that provides housing, support, and amenities at an affordable cost for patients and families. Those amenities are funded through donations to the Patient Assistance Fund.
Recent News
Physician leaders from AdventHealth’s emergency department, infectious disease, inpatient, pediatrics and pharmacy teams all collaborated to develop a respiratory virus testing algorithm to assist...
Thoracic surgeon Colleen Gaughan, MD, and her team at AdventHealth Celebration, recently became one of the first in the country to incorporate targeted imaging agent Cytalux (pafolacianine) as part of...
On the newest Inspiring Wholeness podcast, Obie Diaz, local morning radio show host, shares how a routine physical eventually led to two open heart surgeries.
AdventHealth recently began piloting a new Genomics Risk Assessment for Cancer and Early Detection (GRACE) program that combines the use of digital mammography, artificial intelligence (AI) technology...
AdventHealth Clinical Research Unit (CRU) Executive Director and Medical Director of Genitourinary Oncology Guru Sonpavde, MD, co-authored an article on the AMBASSADOR Phase III clinical trial results...
AdventHealth is accelerating the use of research-backed best practices for treating pediatric respiratory infections to combat antibiotic resistance and improve patient outcomes.
A promising new treatment for AFib patients called Pulse Field Ablation is first offered in Central Florida at AdventHealth and shows less damage to tissue.
Plastic and Reconstructive Microsurgeon Sabrina Pavri, MD, and Breast Surgeon Devina McCray, MD, recently began offering immediate neurotization after breast reconstruction, a new surgical technique...
Explore the importance of Hispanic representation in our community in this episode of the Inspiring Wholeness podcast.
Under the leadership of gynecologist and gynecological surgeon Omar Zwain, MD, AdventHealth for Women opened its new, multidisciplinary Comprehensive Fibroid Program at AdventHealth Winter Park in...
Under the leadership of Medical Director of Genomics and Personalized Health Majed Dasouki, MD, AdventHealth for Children is recruiting patients for a new Phase III clinical trial to evaluate the...
Hepato-pancreato-biliary (HPB) surgeon Andrew Guzowski, MD, performed AdventHealth’s first liver histotripsy, a non-invasive treatment for certain patients with unresectable liver tumors.